View Financial HealthNorthPalm Capital 配当と自社株買い配当金 基準チェック /06NorthPalm Capital配当金を支払った記録がありません。主要情報n/a配当利回り-41.3%バイバック利回り総株主利回り-41.3%将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • Feb 06Scryb Inc., Annual General Meeting, Mar 31, 2026Scryb Inc., Annual General Meeting, Mar 31, 2026.お知らせ • Sep 27Scryb Inc. announced that it has received CAD 1.5 million in fundingOn September 26, 2025, the company closed the transaction.お知らせ • Sep 18Scryb Inc. announced that it expects to receive CAD 0.6 million in fundingScryb Inc. announced a non-brokered private placement of up to 6,000,000 units at a price of CAD 0.10 per Unit, for gross proceeds of up to CAD 600,000 on September 17, 2025. Each Unit will consist of one common share (a "Common Share") and one half of one common share purchase warrant (each a full warrant a "Warrant"). Each Warrant entitles the holder to purchase one Common Share of the Company at a price of CAD 0.18 for a period of eighteen months after closing. The Company may pay a cash finder's fee to certain registered finders (each a "Finder") of up to 7% of the aggregate gross proceeds of subscriptions facilitated by such Finders; and (issue such number of finder's warrants (a "Finder's Warrant") that is equal to up to 7% of the number of Units sourced by the Finder, with each Finder's Warrant entitling the holder thereof to purchase one Common Share (a "Finder's Warrant Share") at an exercise price of CAD 0.18 per Finder's Warrant Share for a period of 18 months following the closing date of the Offering. The securities issued pursuant to the Offering will be subject to a hold period of four months plus one day from the date of closing in accordance with applicable securities laws and the policies of the Canadian Securities Exchange.お知らせ • Jan 06Scryb Inc. announced that it expects to receive CAD 2 million in fundingScryb Inc. announced a non-brokered private placement on January 5, 2025. The company will issue secured convertible debentures for gross proceeds of up to CAD 2,000,000. The Debentures will bear interest at an annual rate of 12% and the outstanding principal and interest can be converted into common shares of the Company at a conversion price of CAD 0.05 per Share. The Debentures will mature two years from the date of issuance, except for the debenture issued to an affiliate of Plaza Capital, the lead investor in the Offering, which will mature one year from the date of issuance. The Company may pay a cash finder's fee to certain eligible finders of up to 7% of the aggregate gross proceeds of the Offering facilitated by such finders. All securities issued will be subject to a four month and one day hold as required under applicable securities laws.お知らせ • Dec 11An unknown buyer acquired an unknown stake in Fionet Rapid Response Group Inc. from Scryb Inc. (CNSX:SCYB) for CAD 4.3 million.An unknown buyer acquired an unknown stake in Fionet Rapid Response Group Inc. from Scryb Inc. (CNSX:SCYB) for CAD 4.3 million on December 6, 2024. An unknown buyer completed the acquisition of an unknown stake in Fionet Rapid Response Group Inc. from Scryb Inc. (CNSX:SCYB) on December 6, 2024.お知らせ • Nov 07Scryb Inc. announced that it has received CAD 0.7424 million in fundingOn November 6, 2024, Scryb Inc. closed the transaction. The company issued 29,696,000 units at a price of CAD 0.025 per unit for gross proceeds of CAD 742,400.Reported Earnings • Sep 01Third quarter 2024 earnings released: CA$0.003 loss per share (vs CA$0.019 loss in 3Q 2023)Third quarter 2024 results: CA$0.003 loss per share (improved from CA$0.019 loss in 3Q 2023). Revenue: CA$8.2k (down 98% from 3Q 2023). Net loss: CA$894.4k (loss narrowed 81% from 3Q 2023). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 52% per year, which means it is significantly lagging earnings.お知らせ • Aug 07Scryb Inc. announced that it expects to receive CAD 1 million in fundingScryb Inc. announced a non brokered private placement financing to issue 40,000,000 units at an issue price of CAD 0.025 per Unit for the gross proceeds of CAD 1,000,000 on August 6, 2024. Each Unit shall be comprised of one common share and one whole Common Share purchase warrant. Each Warrant entitles the holder thereof to acquire one Common Share at a price of CAD 0.05 per Common Share until the date that is eighteen months from the date of issuance. Closing of the Offering is subject to receipt of all necessary corporate and regulatory approvals, including the approval of Canadian Securities Exchange. All securities issued in connection with the Offering will be subject to a hold period of four months plus a day from the date of issuance and the resale rules of applicable securities legislation.Reported Earnings • Jun 04Second quarter 2024 earnings released: CA$0.016 loss per share (vs CA$0.007 loss in 2Q 2023)Second quarter 2024 results: CA$0.016 loss per share (further deteriorated from CA$0.007 loss in 2Q 2023). Revenue: CA$492.8k (down 23% from 2Q 2023). Net loss: CA$4.05m (loss widened 153% from 2Q 2023). Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 55% per year, which means it is significantly lagging earnings.New Risk • Jun 03New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 13% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (42% average weekly change). Earnings have declined by 20% per year over the past 5 years. Market cap is less than US$10m (€4.92m market cap, or US$5.34m). Minor Risks Shareholders have been diluted in the past year (13% increase in shares outstanding). Revenue is less than US$5m (CA$2.0m revenue, or US$1.5m).お知らせ • Apr 02Scryb Inc. announced that it expects to receive CAD 1.5 million in fundingScryb Inc. announced a non-brokered private placement financing to issue 60,000,000 units at an issue price of CAD 0.025 per unit for the gross proceeds of CAD 1,500,000 on April 1, 2024. Each Unit shall be comprised of one common share and one whole Common Share purchase warrant. Each Warrant entitles the holder thereof to acquire one Common Share at a price of CAD 0.05 per Common Share until the date that is eighteen months from the date of issuance. Closing of the Offering is subject to receipt of all necessary corporate and regulatory approvals, including the approval of Canadian Securities Exchange. All securities issued in connection with the Offering will be subject to a hold period of four months plus a day from the date of issuance and the resale rules of applicable securities legislation.お知らせ • Mar 13Scryb Inc. Announces Board of Directors ChangesScryb Inc. announced the appointment of Yoav Raiter to its Board of Directors, effective immediately. Yoav remains the Chief Executive Officer of Scryb. In addition, the Company announced that Mr. Medhanie Tekeste has resigned as a Director of Scryb.Reported Earnings • Mar 03First quarter 2024 earnings released: CA$0.011 loss per share (vs CA$0.036 loss in 1Q 2023)First quarter 2024 results: CA$0.011 loss per share (improved from CA$0.036 loss in 1Q 2023). Revenue: CA$485.2k (up 343% from 1Q 2023). Net loss: CA$2.90m (loss narrowed 66% from 1Q 2023).Board Change • Mar 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. 1 highly experienced director. President & Director W. Kent was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.お知らせ • Feb 29Scryb Inc., Annual General Meeting, Apr 23, 2024Scryb Inc., Annual General Meeting, Apr 23, 2024.Reported Earnings • Feb 06Full year 2023 earnings released: CA$0.08 loss per share (vs CA$0.046 loss in FY 2022)Full year 2023 results: CA$0.08 loss per share (further deteriorated from CA$0.046 loss in FY 2022). Revenue: CA$1.59m (up 138% from FY 2022). Net loss: CA$19.8m (loss widened 77% from FY 2022).New Risk • Sep 30New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €8.96m (US$9.47m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$15m free cash flow). Share price has been highly volatile over the past 3 months (35% average weekly change). Earnings have declined by 21% per year over the past 5 years. Market cap is less than US$10m (€8.96m market cap, or US$9.47m). Minor Risks Shareholders have been diluted in the past year (7.3% increase in shares outstanding). Revenue is less than US$5m (CA$1.6m revenue, or US$1.2m).New Risk • Sep 03New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$15m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$15m free cash flow). Share price has been highly volatile over the past 3 months (29% average weekly change). Earnings have declined by 21% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (7.2% increase in shares outstanding). Revenue is less than US$5m (CA$1.6m revenue, or US$1.2m). Market cap is less than US$100m (€12.3m market cap, or US$13.2m).Reported Earnings • Jun 02Second quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.011 loss in 2Q 2022)Second quarter 2023 results: CA$0.007 loss per share (improved from CA$0.011 loss in 2Q 2022). Net loss: CA$1.60m (loss narrowed 38% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.お知らせ • May 11Scryb Inc. announced that it has received CAD 2.165 million in fundingOn May 10, 2023, Scryb Inc. closed the transaction. The company amended the terms of the transaction. The company issued 6,765,000 units at an issue price of CAD 0.125 per unit for gross proceeds of CAD 845,625 in its second and final tranche. The company has issued 17,320,000 units for gross proceeds of CAD 2,165,000. The company paid finder's fees of CAD 7,500 and issued 60,000 units.お知らせ • Dec 10Scryb Inc., Annual General Meeting, Feb 22, 2023Scryb Inc., Annual General Meeting, Feb 22, 2023.Board Change • Nov 16High number of new and inexperienced directorsThere are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 3 experienced directors. 1 highly experienced director. Independent Director Mike Minder is the most experienced director on the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Board Change • Apr 28High number of new and inexperienced directorsThere are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 4 experienced directors. No highly experienced directors. Independent Director Mike Minder is the most experienced director on the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Recent Insider Transactions • Nov 28President & Director recently bought €2.3m worth of stockOn the 25th of November, W. Kent bought around 166k shares on-market at roughly €13.74 per share. This was the largest purchase by an insider in the last 3 months. W. has been a buyer over the last 12 months, purchasing a net total of €2.4m worth in shares.Breakeven Date Change • Jul 27Forecast to breakeven in 2022The analyst covering Relay Medical expects the company to break even for the first time. New forecast suggests the company will make a profit of CA$375.0k in 2022. Average annual earnings growth of 104% is required to achieve expected profit on schedule.Is New 90 Day High Low • Jan 22New 90-day high: €0.21The company is up 48% from its price of €0.14 on 23 October 2020. The German market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Medical Equipment industry, which is up 12% over the same period.決済の安定と成長配当データの取得安定した配当: EIY0の 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: EIY0の配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場NorthPalm Capital 配当利回り対市場EIY0 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (EIY0)n/a市場下位25% (DE)1.5%市場トップ25% (DE)4.6%業界平均 (Software)1.8%アナリスト予想 (EIY0) (最長3年)n/a注目すべき配当: EIY0は最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: EIY0は最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: EIY0の 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: EIY0が配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YDE 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/06 19:20終値2026/05/06 00:00収益2025/12/31年間収益2025/09/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋NorthPalm Capital Corp 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Theodore O'NeillLitchfield Hills Research, LLC
お知らせ • Feb 06Scryb Inc., Annual General Meeting, Mar 31, 2026Scryb Inc., Annual General Meeting, Mar 31, 2026.
お知らせ • Sep 27Scryb Inc. announced that it has received CAD 1.5 million in fundingOn September 26, 2025, the company closed the transaction.
お知らせ • Sep 18Scryb Inc. announced that it expects to receive CAD 0.6 million in fundingScryb Inc. announced a non-brokered private placement of up to 6,000,000 units at a price of CAD 0.10 per Unit, for gross proceeds of up to CAD 600,000 on September 17, 2025. Each Unit will consist of one common share (a "Common Share") and one half of one common share purchase warrant (each a full warrant a "Warrant"). Each Warrant entitles the holder to purchase one Common Share of the Company at a price of CAD 0.18 for a period of eighteen months after closing. The Company may pay a cash finder's fee to certain registered finders (each a "Finder") of up to 7% of the aggregate gross proceeds of subscriptions facilitated by such Finders; and (issue such number of finder's warrants (a "Finder's Warrant") that is equal to up to 7% of the number of Units sourced by the Finder, with each Finder's Warrant entitling the holder thereof to purchase one Common Share (a "Finder's Warrant Share") at an exercise price of CAD 0.18 per Finder's Warrant Share for a period of 18 months following the closing date of the Offering. The securities issued pursuant to the Offering will be subject to a hold period of four months plus one day from the date of closing in accordance with applicable securities laws and the policies of the Canadian Securities Exchange.
お知らせ • Jan 06Scryb Inc. announced that it expects to receive CAD 2 million in fundingScryb Inc. announced a non-brokered private placement on January 5, 2025. The company will issue secured convertible debentures for gross proceeds of up to CAD 2,000,000. The Debentures will bear interest at an annual rate of 12% and the outstanding principal and interest can be converted into common shares of the Company at a conversion price of CAD 0.05 per Share. The Debentures will mature two years from the date of issuance, except for the debenture issued to an affiliate of Plaza Capital, the lead investor in the Offering, which will mature one year from the date of issuance. The Company may pay a cash finder's fee to certain eligible finders of up to 7% of the aggregate gross proceeds of the Offering facilitated by such finders. All securities issued will be subject to a four month and one day hold as required under applicable securities laws.
お知らせ • Dec 11An unknown buyer acquired an unknown stake in Fionet Rapid Response Group Inc. from Scryb Inc. (CNSX:SCYB) for CAD 4.3 million.An unknown buyer acquired an unknown stake in Fionet Rapid Response Group Inc. from Scryb Inc. (CNSX:SCYB) for CAD 4.3 million on December 6, 2024. An unknown buyer completed the acquisition of an unknown stake in Fionet Rapid Response Group Inc. from Scryb Inc. (CNSX:SCYB) on December 6, 2024.
お知らせ • Nov 07Scryb Inc. announced that it has received CAD 0.7424 million in fundingOn November 6, 2024, Scryb Inc. closed the transaction. The company issued 29,696,000 units at a price of CAD 0.025 per unit for gross proceeds of CAD 742,400.
Reported Earnings • Sep 01Third quarter 2024 earnings released: CA$0.003 loss per share (vs CA$0.019 loss in 3Q 2023)Third quarter 2024 results: CA$0.003 loss per share (improved from CA$0.019 loss in 3Q 2023). Revenue: CA$8.2k (down 98% from 3Q 2023). Net loss: CA$894.4k (loss narrowed 81% from 3Q 2023). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 52% per year, which means it is significantly lagging earnings.
お知らせ • Aug 07Scryb Inc. announced that it expects to receive CAD 1 million in fundingScryb Inc. announced a non brokered private placement financing to issue 40,000,000 units at an issue price of CAD 0.025 per Unit for the gross proceeds of CAD 1,000,000 on August 6, 2024. Each Unit shall be comprised of one common share and one whole Common Share purchase warrant. Each Warrant entitles the holder thereof to acquire one Common Share at a price of CAD 0.05 per Common Share until the date that is eighteen months from the date of issuance. Closing of the Offering is subject to receipt of all necessary corporate and regulatory approvals, including the approval of Canadian Securities Exchange. All securities issued in connection with the Offering will be subject to a hold period of four months plus a day from the date of issuance and the resale rules of applicable securities legislation.
Reported Earnings • Jun 04Second quarter 2024 earnings released: CA$0.016 loss per share (vs CA$0.007 loss in 2Q 2023)Second quarter 2024 results: CA$0.016 loss per share (further deteriorated from CA$0.007 loss in 2Q 2023). Revenue: CA$492.8k (down 23% from 2Q 2023). Net loss: CA$4.05m (loss widened 153% from 2Q 2023). Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 55% per year, which means it is significantly lagging earnings.
New Risk • Jun 03New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 13% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (42% average weekly change). Earnings have declined by 20% per year over the past 5 years. Market cap is less than US$10m (€4.92m market cap, or US$5.34m). Minor Risks Shareholders have been diluted in the past year (13% increase in shares outstanding). Revenue is less than US$5m (CA$2.0m revenue, or US$1.5m).
お知らせ • Apr 02Scryb Inc. announced that it expects to receive CAD 1.5 million in fundingScryb Inc. announced a non-brokered private placement financing to issue 60,000,000 units at an issue price of CAD 0.025 per unit for the gross proceeds of CAD 1,500,000 on April 1, 2024. Each Unit shall be comprised of one common share and one whole Common Share purchase warrant. Each Warrant entitles the holder thereof to acquire one Common Share at a price of CAD 0.05 per Common Share until the date that is eighteen months from the date of issuance. Closing of the Offering is subject to receipt of all necessary corporate and regulatory approvals, including the approval of Canadian Securities Exchange. All securities issued in connection with the Offering will be subject to a hold period of four months plus a day from the date of issuance and the resale rules of applicable securities legislation.
お知らせ • Mar 13Scryb Inc. Announces Board of Directors ChangesScryb Inc. announced the appointment of Yoav Raiter to its Board of Directors, effective immediately. Yoav remains the Chief Executive Officer of Scryb. In addition, the Company announced that Mr. Medhanie Tekeste has resigned as a Director of Scryb.
Reported Earnings • Mar 03First quarter 2024 earnings released: CA$0.011 loss per share (vs CA$0.036 loss in 1Q 2023)First quarter 2024 results: CA$0.011 loss per share (improved from CA$0.036 loss in 1Q 2023). Revenue: CA$485.2k (up 343% from 1Q 2023). Net loss: CA$2.90m (loss narrowed 66% from 1Q 2023).
Board Change • Mar 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. 1 highly experienced director. President & Director W. Kent was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
お知らせ • Feb 29Scryb Inc., Annual General Meeting, Apr 23, 2024Scryb Inc., Annual General Meeting, Apr 23, 2024.
Reported Earnings • Feb 06Full year 2023 earnings released: CA$0.08 loss per share (vs CA$0.046 loss in FY 2022)Full year 2023 results: CA$0.08 loss per share (further deteriorated from CA$0.046 loss in FY 2022). Revenue: CA$1.59m (up 138% from FY 2022). Net loss: CA$19.8m (loss widened 77% from FY 2022).
New Risk • Sep 30New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €8.96m (US$9.47m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$15m free cash flow). Share price has been highly volatile over the past 3 months (35% average weekly change). Earnings have declined by 21% per year over the past 5 years. Market cap is less than US$10m (€8.96m market cap, or US$9.47m). Minor Risks Shareholders have been diluted in the past year (7.3% increase in shares outstanding). Revenue is less than US$5m (CA$1.6m revenue, or US$1.2m).
New Risk • Sep 03New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$15m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$15m free cash flow). Share price has been highly volatile over the past 3 months (29% average weekly change). Earnings have declined by 21% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (7.2% increase in shares outstanding). Revenue is less than US$5m (CA$1.6m revenue, or US$1.2m). Market cap is less than US$100m (€12.3m market cap, or US$13.2m).
Reported Earnings • Jun 02Second quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.011 loss in 2Q 2022)Second quarter 2023 results: CA$0.007 loss per share (improved from CA$0.011 loss in 2Q 2022). Net loss: CA$1.60m (loss narrowed 38% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.
お知らせ • May 11Scryb Inc. announced that it has received CAD 2.165 million in fundingOn May 10, 2023, Scryb Inc. closed the transaction. The company amended the terms of the transaction. The company issued 6,765,000 units at an issue price of CAD 0.125 per unit for gross proceeds of CAD 845,625 in its second and final tranche. The company has issued 17,320,000 units for gross proceeds of CAD 2,165,000. The company paid finder's fees of CAD 7,500 and issued 60,000 units.
お知らせ • Dec 10Scryb Inc., Annual General Meeting, Feb 22, 2023Scryb Inc., Annual General Meeting, Feb 22, 2023.
Board Change • Nov 16High number of new and inexperienced directorsThere are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 3 experienced directors. 1 highly experienced director. Independent Director Mike Minder is the most experienced director on the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Board Change • Apr 28High number of new and inexperienced directorsThere are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 4 experienced directors. No highly experienced directors. Independent Director Mike Minder is the most experienced director on the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Recent Insider Transactions • Nov 28President & Director recently bought €2.3m worth of stockOn the 25th of November, W. Kent bought around 166k shares on-market at roughly €13.74 per share. This was the largest purchase by an insider in the last 3 months. W. has been a buyer over the last 12 months, purchasing a net total of €2.4m worth in shares.
Breakeven Date Change • Jul 27Forecast to breakeven in 2022The analyst covering Relay Medical expects the company to break even for the first time. New forecast suggests the company will make a profit of CA$375.0k in 2022. Average annual earnings growth of 104% is required to achieve expected profit on schedule.
Is New 90 Day High Low • Jan 22New 90-day high: €0.21The company is up 48% from its price of €0.14 on 23 October 2020. The German market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Medical Equipment industry, which is up 12% over the same period.